After a reviewing the evidence from non-clinical studies, clinical trials, and data from post-marketing surveillance, The European Medicines Agency (EMA) committee concluded that NAION is associated with use of semaglutide (the active ingredient in Ozempic and Wegovy)
Missing the mark risks fines, withdrawal, or blocked entry
Starting with just looking at injection supplies, then handling them, then practicing on a cushion, before finally self-injecting follows evidence based principles for overcoming anxiety
At Blue Horizon, we believe the best health decisions are made with a full clinical picture
However, they are serious and should be factored into the riskbenefit discussion when considering GLP-1 therapy with a doctor